ArticleRambam Maimonides medical journal2016
Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders.
Article in Rambam Maimonides medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.
- Physicians' experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review.BMC family practice · 2021Pooled it
- Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis - A systematic review.PloS one · 2019Pooled it
- Cannabinoids in Pain Management and Palliative Medicine.Deutsches Arzteblatt international · 2017Pooled it
- Knowledge, Attitudes, and Clinical Experience with Cannabinoid Therapies: A Cross-Sectional Survey of Rheumatologists.Mediterranean journal of rheumatology · 2026Article
- Concerns, Beliefs and Attitudes of Pharmacists About Medical Cannabis Use in Poland.Healthcare (Basel, Switzerland) · 2025Article
- Neurologists' perspectives of cannabis-based medicines: results from an all-Ireland survey.Irish journal of medical science · 2025Article
- Fibromyalgia: do I tackle you with pharmacological treatments?Pain reports · 2025Review
- Review
- Knowledge, perception, and beliefs of Saudi physicians at King Abdulaziz Medical City, Riyadh related to medical cannabis: Literature review and a cross-sectional survey.Journal of family medicine and primary care · 2023Article
- Physician Perceptions of Cannabidiol (CBD) and Cannabis in Sports Medicine and Performance.Translational sports medicine · 2023Article
- The evolving culture of medical cannabis in Canada for the management of chronic pain.Frontiers in pharmacology · 2023Review
- Healthcare professionals' perspectives on the use of medicinal cannabis to manage chronic pain: A systematic search and narrative review.Pain practice : the official journal of World Institute of Pain · 2022Review
- Impact of cannabis knowledge and attitudes on real-world practice.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022Article
- Assessing Health Care Providers' Knowledge of Medical Cannabis.Cannabis and cannabinoid research · 2022Article
- A systematic review of medical students' and professionals' attitudes and knowledge regarding medical cannabis.Journal of cannabis research · 2021Review
- Article
- [Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety : Experiences of pain physicians in Saarland].Schmerz (Berlin, Germany) · 2019Review
- Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain.Journal of pain research · 2018Article
- Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey.Harm reduction journal · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile medical cannabis has been used for thousands of years in the treatment of pain and other symptoms, evidence-based use is limited and practitioners face multiple areas of uncertainty regarding the rational use of these compounds. Nonetheless, an increasing public interest and advocacy in favor of medical cannabis is causing the issue to be encountered ever more frequently by physicians in different fields of medicine and particularly in rheumatology. In view of this situation, we have surveyed the attitudes of Israeli rheumatologists to the use of medical cannabis.
objectivesAs rheumatologists are specialized in caring for patients presenting with musculoskeletal complaints, the confidence of rheumatologists' knowledge of cannabinoids was surveyed.
methodsAll members of the Israeli Society of Rheumatology were surveyed by e-mail for their confidence and knowledge of cannabinoids and their perceived competence to prescribe herbal cannabis.
resultsA total of 23 out of 119 (19.3%) Israeli rheumatologists approached returned the questionnaire. Three-quarters of responders were not confident about their knowledge of cannabinoid molecules or ability to write a prescription for herbal cannabis, and 78% were not confident to write a prescription for herbal cannabis; 74% of responders held the opinion that there was some role for cannabinoids in the management of rheumatic disease.
conclusionIsraeli rheumatologists lack confidence in their knowledge of cannabinoids in general, yet are open to the possibility of introducing this treatment. Additional data and guidance are necessary in order to allow rational utilization of cannabinoids for management of rheumatic pain.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.